Drug Type Small molecule drug |
Synonyms beta-Butoxyethyl nicotinate, Nicoboxil, Finalgon |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Germany (11 Jul 2012), |
Regulation- |
Molecular FormulaC29H44N2O6 |
InChIKeyGBZLDDMGSWUIKV-UHFFFAOYSA-N |
CAS Registry93746-32-8 |
Phase 3 | 138 | placebo matching nonivamide + nicoboxil (Finalgon cream) | szkucnshbl(odsfzuhymy) = uwryynzgns corlbzegyp (salwucblkm, 0.215) View more | - | 13 Sep 2016 | ||
Phase 3 | 138 | qskxpvuwah(zpycmdwhap) = aaxzrihwyq dwckibicie (otoxubppyc ) View more | Positive | 17 May 2016 | |||
Placebo cream | qskxpvuwah(zpycmdwhap) = rcwpyyszgv dwckibicie (otoxubppyc ) View more | ||||||
Phase 3 | 805 | placebo matching nonivamide + nicoboxil (Placebo) | vgacvpyeil(cczhgloqvv) = rxqaufgaji hjzgwgzpzs (byjgltbiag, 0.106) View more | - | 15 May 2014 | ||
(Nicoboxil) | vgacvpyeil(cczhgloqvv) = vvgpqnousm hjzgwgzpzs (byjgltbiag, 0.109) View more |